메뉴 건너뛰기




Volumn 19, Issue 9, 2010, Pages 901-910

Adverse drug events in the outpatient setting: An 11-year national analysis

Author keywords

Adverse drug events; Outpatients; Polypharmacy

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ANALGESIC AGENT; ANESTHETIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BENZODIAZEPINE DERIVATIVE; CARDIOTONIC AGENT; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; CENTRAL STIMULANT AGENT; CEPHALOSPORIN DERIVATIVE; CORTICOSTEROID; DIURETIC AGENT; ESTROGEN; HORMONE; INSULIN; MACROLIDE; MOOD STABILIZER; NEUROLEPTIC AGENT; PENICILLIN DERIVATIVE; PROGESTERONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SEDATIVE AGENT; SULFONAMIDE; TETRACYCLINE DERIVATIVE; UNINDEXED DRUG;

EID: 77957354831     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1984     Document Type: Article
Times cited : (251)

References (26)
  • 1
    • 0032522873 scopus 로고    scopus 로고
    • Incidence of adverse drug reactions in hospitalized patients: A meta- Analysis of prospective studies
    • DOI 10.1001/jama.279.15.1200
    • Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279(15): 1200-1205. (Pubitemid 28193431)
    • (1998) Journal of the American Medical Association , vol.279 , Issue.15 , pp. 1200-1205
    • Lazarou, J.1    Pomeranz, B.H.2    Corey, P.N.3
  • 2
    • 0029066463 scopus 로고
    • Incidence of adverse drug events and potential adverse drug events. Implications for prevention
    • ADE Prevention Study Group
    • Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 1995; 274(1): 29-34.
    • (1995) JAMA , vol.274 , Issue.1 , pp. 29-34
    • Bates, D.W.1    Cullen, D.J.2    Laird, N.3
  • 3
    • 0031032055 scopus 로고    scopus 로고
    • Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality
    • Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1997; 277(4): 301-306.
    • (1997) JAMA , vol.277 , Issue.4 , pp. 301-306
    • Classen, D.C.1    Pestotnik, S.L.2    Evans, R.S.3    Lloyd, J.F.4    Burke, J.P.5
  • 6
    • 34548563740 scopus 로고    scopus 로고
    • Adverse drug events in pediatric outpatients
    • Kaushal R, Goldmann DA, Keohane CA, et al. Adverse drug events in pediatric outpatients. Ambul Pediatr 2007; 7(5): 383-389.
    • (2007) Ambul Pediatr , vol.7 , Issue.5 , pp. 383-389
    • Kaushal, R.1    Goldmann, D.A.2    Keohane, C.A.3
  • 8
    • 0037024691 scopus 로고    scopus 로고
    • National ambulatory medical care survey: 2005: summary
    • Cherry DK, Woodwell DA, Rechtsteiner EA. National ambulatory medical care survey: 2005: summary. Adv Data 2007; 387: 1-39.
    • (2007) Adv Data , vol.387 , pp. 1-39
    • Cherry, D.K.1    Woodwell, D.A.2    Rechtsteiner, E.A.3
  • 10
    • 15744386347 scopus 로고    scopus 로고
    • Adverse drug reaction risk factors in older outpatients
    • Hajjar ER, Hanlon JT, Artz MB, et al. Adverse drug reaction risk factors in older outpatients. Am J Geriatr Pharmacother 2003; 1(2): 82-89.
    • (2003) Am J Geriatr Pharmacother , vol.1 , Issue.2 , pp. 82-89
    • Hajjar, E.R.1    Hanlon, J.T.2    Artz, M.B.3
  • 11
    • 0037451920 scopus 로고    scopus 로고
    • Adverse drug events in ambulatory care
    • Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med 2003; 348(16): 1556-1564.
    • (2003) N Engl J Med , vol.348 , Issue.16 , pp. 1556-1564
    • Gandhi, T.K.1    Weingart, S.N.2    Borus, J.3
  • 12
    • 0037420274 scopus 로고    scopus 로고
    • Incidence and preventability of adverse drug events among older persons in the ambulatory setting
    • Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003; 289(9): 1107-1116.
    • (2003) JAMA , vol.289 , Issue.9 , pp. 1107-1116
    • Gurwitz, J.H.1    Field, T.S.2    Harrold, L.R.3
  • 14
    • 70349734624 scopus 로고    scopus 로고
    • Pediatric adverse drug events in the outpatient setting: An 11-year national analysis
    • Bourgeois F, Mandl K, Shannon M. Pediatric adverse drug events in the outpatient setting: an 11-year national analysis. Pediatrics 2009; 124(4): e744-e750.
    • (2009) Pediatrics , vol.124 , Issue.4
    • Bourgeois, F.1    Mandl, K.2    Shannon, M.3
  • 15
    • 33846679894 scopus 로고    scopus 로고
    • National Center for Health Statistics accessed 3 August 2009
    • National Center for Health Statistics. Ambulatory Healthcare Data. http://www.cdc.gov/nchs/about/major/ahcd/ahcd1.htm (accessed 3 August 2009).
    • Ambulatory Healthcare Data
  • 20
    • 33646789156 scopus 로고    scopus 로고
    • Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents
    • DOI 10.1016/j.amjopharm.2006.03.002, PII S1543594606000031
    • Nguyen JK, Fouts MM, Kotabe SE, Lo E. Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. Am J Geriatr Pharmacother 2006; 4(1): 36-41. (Pubitemid 43758180)
    • (2006) American Journal Geriatric Pharmacotherapy , vol.4 , Issue.1 , pp. 36-41
    • Nguyen, J.K.1    Fouts, M.M.2    Kotabe, S.E.3    Lo, E.4
  • 21
    • 0036020411 scopus 로고    scopus 로고
    • Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: A longitudinal population-based study
    • DOI 10.1007/s00228-002-0467-0
    • Schneeweiss S, Hasford J, Gottler M, Hoffmann A, Riethling AK, Avorn J. Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population- based study. Eur J Clin Pharmacol 2002; 58(4): 285-291. (Pubitemid 34827858)
    • (2002) European Journal of Clinical Pharmacology , vol.58 , Issue.4 , pp. 285-291
    • Schneeweiss, S.1    Hasford, J.2    Gottler, M.3    Hoffmann, A.4    Riethling, A.-K.5    Avorn, J.6
  • 23
    • 0022456755 scopus 로고
    • Frequency, severity and risk factors for adverse drug reactions in adult out-patients: A prospective study
    • Hutchinson TA, Flegel KM, Kramer MS, Leduc DG, Kong HH. Frequency, severity and risk factors for adverse drug reactions in adult out-patients: a prospective study. J Chronic Dis 1986; 39(7): 533-542.
    • (1986) J Chronic Dis , vol.39 , Issue.7 , pp. 533-542
    • Hutchinson, T.A.1    Flegel, K.M.2    Kramer, M.S.3    Leduc, D.G.4    Kong, H.H.5
  • 24
    • 32944473629 scopus 로고    scopus 로고
    • Ambulatory care visits for treating adverse drug effects in the United States, 1995-2001
    • Zhan C, Arispe I, Kelley E, et al. Ambulatory care visits for treating adverse drug effects in the United States, 1995-2001. Jt Comm J Qual Patient Saf 2005; 31(7): 372-378.
    • (2005) Jt Comm J Qual Patient Saf , vol.31 , Issue.7 , pp. 372-378
    • Zhan, C.1    Arispe, I.2    Kelley, E.3
  • 26
    • 0034253924 scopus 로고    scopus 로고
    • Incidence and preventability of adverse drug events in nursing homes
    • Gurwitz JH, Field TS, Avorn J, et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000; 109(2): 87-94.
    • (2000) Am J Med , vol.109 , Issue.2 , pp. 87-94
    • Gurwitz, J.H.1    Field, T.S.2    Avorn, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.